Healthtech Investors & VC Firms
3408 firms in this list, with a median first check of $500K. 737 of them lead rounds. Generated from verified public data and updated continuously.
Rock Health
Pre-Seed–Series A
22 people
Chingona Ventures
ChicagoPre-Seed–Seed$250K – $2M
9 people
Elysian Park Ventures
Los AngelesPre-Seed–Late Stage$500K – $100M
15 people
H.I.G. HealthBridge Partners
MiamiGrowth$5M – $40M
15 people
Prysm Capital
San FranciscoGrowth–Late Stage
18 people
Spiral Ventures
SingaporePre-Seed–Growth$1M
9 people
Venture Ontario
TorontoSeed–Growth
3 people
IvyCap Ventures
MumbaiPre-Seed–Series B$300K – $33M
11 people
Jacobs Holding AG
ZurichGrowth–Late Stage$100M – $300M
23 people
Magnum Industrial Partners Tres S.L.
MadridGrowth–Late Stage
17 people
Oceans Ventures
New YorkPre-Seed–Series A$1.3M
5 people
PICO Venture Partners
JerusalemPre-Seed–Series A$600K – $54M
17 people
Roo Capital
New YorkPre-Seed–Series A$500K – $25M
14 people
Union Square Advisors LLC
San Francisco
26 people
Vetted Accelerator
MiamiPre-Seed–Seed
26 people
ECP Growth
GreenwichGrowth
13 people
The Sovereign Fund of Egypt
CairoLate Stage
25 people
Ubiquity Ventures
Palo AltoPre-Seed–Series A$1M – $3M
4 people
Hiroshima Venture Capital Co. Ltd.
HiroshimaPre-Seed–Late Stage
PACE Healthcare Capital
ChicagoSeed–Series B$1M – $4M
18 people
Phaze Ventures
MuscatPre-Seed–Growth$1M – $22M
9 people
Qbic Fund
St-Denijs-WestremPre-Seed–Series A
18 people
Oncology Ventures
New YorkSeed–Series B
17 people
Pathlight Ventures
Old BridgePre-Seed–Series A$500K – $5M
5 people
Related lists
Investors & VC Firms in North America (13808)Investors & VC Firms in United States (12951)Investors & VC Firms in Europe (5511)Crypto & Web3 Investors & VC Firms (4813)Investors & VC Firms in Global (4134)SaaS Investors & VC Firms (3860)AI & Machine Learning Investors & VC Firms (3764)Fintech Investors & VC Firms (3709)Investors & VC Firms in Asia-Pacific (3560)Enterprise Software Investors & VC Firms (3215)
Data sourced from public filings and firms' own websites — see our methodology.








































































































